Veeva says its new AI agent can build a clinical study in a day
Peter Gassner built Veeva around life sciences software; its new agent will configure EDC and data-quality systems from study protocols, with early access planned for December.
By RuntimeWire Staff · Published
Primary source: PR Newswire
Why it matters
Veeva is putting AI inside a specialized clinical-data workflow and tying it to customer standards and its existing EDC product. The one-day claim remains unsubstantiated by customer results, while the December early-access program will test whether speed translates into reviewable, production-ready study configurations.
Veeva Systems (Veeva) says its new Study Builder Agent can configure a clinical study in as little as one day, turning a protocol into forms, visits, edit checks and data-quality listings for its clinical software. Veeva announced the product on September 24th; early-adopter access is planned for December 2026.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.